Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer

dc.contributor.author	Antolín Novoa, Silvia
dc.date.accessioned	2017-06-07T07:36:54Z
dc.date.available	2017-06-07T07:36:54Z
dc.date.issued	2014
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/8526
dc.language.iso	eng
dc.title	Phase I study of dasatinib in combination with trastuzumab and paclitaxel in patients with HER2 positive metastatic breast cancer
dc.type	Publicación de congreso
dc.authorsophos	Gil, M.
dc.authorsophos	Martin, M.
dc.authorsophos	Antolin, S.
dc.authorsophos	Trigo, J. M.
dc.authorsophos	Guerrero, A.
dc.authorsophos	Vidal, L.
dc.authorsophos	Urruticoechea, A.
dc.authorsophos	Pandiella, A.
dc.authorsophos	Hernando, A.
dc.authorsophos	Ocana, A.
dc.identifier.sophos	15383
dc.issue.number	S
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	S180
dc.page.final	S180
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	50

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.